Education
About Us
Working with TipRanks
Follow Us
Neuland Laboratories Ltd. (IN:NEULANDLAB)
:NEULANDLAB
Total Valuation
Neuland Laboratories Ltd. has a market cap or net worth of ₹153.22B. The enterprise value is ₹158.17B.
Market Cap₹153.22B
Enterprise Value₹158.17B
Share Statistics
Neuland Laboratories Ltd. has 12,829,889 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding12,829,889
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Neuland Laboratories Ltd.’s return on equity (ROE) is 0.23 and return on invested capital (ROIC) is 27.49%.
Return on Equity (ROE)0.23
Return on Assets (ROA)0.16
Return on Invested Capital (ROIC)27.49%
Return on Capital Employed (ROCE)0.38
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover0.85
Inventory Turnover2.09
Valuation Ratios
The current PE Ratio of Neuland Laboratories Ltd. is 26.79. Neuland Laboratories Ltd.’s PEG ratio is 0.32.
PE Ratio26.79
PS Ratio0.00
PB Ratio6.27
Price to Fair Value6.27
Price to FCF68.41
Price to Operating Cash Flow30.78
PEG Ratio0.32
Income Statement
In the last 12 months, Neuland Laboratories Ltd. had revenue of 15.59B and earned 3.00B in profits. Earnings per share was 233.89.
Revenue15.59B
Gross Profit8.25B
Operating Income5.32B
Pretax Income4.01B
Net Income3.00B
EBITDA4.75B
Earnings Per Share (EPS)233.89
Cash Flow
In the last 12 months, operating cash flow was 593.03M and capital expenditures 0.00, giving a free cash flow of 593.03M billion.
Operating Cash Flow593.03M
Free Cash Flow593.03M
Free Cash Flow per Share46.22
Dividends & Yields
Neuland Laboratories Ltd. pays an annual dividend of ₹14, resulting in a dividend yield of 0.12%
Dividend Per Share₹14
Dividend Yield0.12%
Payout Ratio7.44%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.95
52-Week Price Change58.65%
50-Day Moving Average11.85K
200-Day Moving Average12.70K
Relative Strength Index (RSI)54.06
Average Volume (3m)2.04K
Important Dates
Neuland Laboratories Ltd. upcoming earnings date is May 13, 2025, TBA Not Confirmed.
Last Earnings DateFeb 10, 2025
Next Earnings DateMay 13, 2025
Ex-Dividend DateJul 12, 2024
Financial Position
Neuland Laboratories Ltd. as a current ratio of 2.15, with Debt / Equity ratio of 7.85%
Current Ratio2.15
Quick Ratio1.33
Debt to Market Cap0.01
Net Debt to EBITDA0.02
Interest Coverage Ratio37.99
Taxes
In the past 12 months, Neuland Laboratories Ltd. has paid 1.01B in taxes.
Income Tax1.01B
Effective Tax Rate0.25
Enterprise Valuation
Neuland Laboratories Ltd. EV to EBITDA ratio is 16.95, with an EV/FCF ratio of 68.48.
EV to Sales5.16
EV to EBITDA16.95
EV to Free Cash Flow68.48
EV to Operating Cash Flow30.81
Balance Sheet
Neuland Laboratories Ltd. has ₹875.75M in cash and marketable securities with ₹953.90M in debt, giving a net cash position of -₹875.75M billion.
Cash & Marketable Securities₹875.75M
Total Debt₹953.90M
Net Cash-₹875.75M
Net Cash Per Share-₹68.26
Tangible Book Value Per Share₹780.04
Margins
Gross margin is 44.70%, with operating margin of 34.12%, and net profit margin of 19.25%.
Gross Margin44.70%
Operating Margin34.12%
Pretax Margin25.76%
Net Profit Margin19.25%
EBITDA Margin30.46%
EBIT Margin26.65%
Analyst Forecast
The average price target for Neuland Laboratories Ltd. is ₹14,700.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target₹14,700.00
Price Target Upside21.64% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast―